Board in-principle approval for preferential equity share issue
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.1 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Neogen Chemicals Board has given in-principle approval to raise funds through a preferential issue of equity shares. Specifics on issue size, pricing, and allottees are not yet disclosed. Separately, Q3 FY26 standalone results show revenue of Rs 215.60 cr and PAT of Rs 8.77 cr; 9M FY26 standalone PAT was Rs 32.30 cr. Dahej fire insurance claim process continues.
Existing shareholders may see equity dilution; details on size, price, and identity of allottees awaited.